Goldman Sachs downgraded Zealand Pharma to Buy from Conviction Buy. The firm removed the shares from its European Conviction List as part of its monthly “Directors’ Cut” update.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
